Global Status Report on Cancer 2026: Cancer disparities — availability of the top 20 priority cancer medicines ranges from just 9% to 54% in low- and lower-middle-income countries, compared with 68% to 94% in high-income countries
Global Status Report on Cancer 2026: Cancer disparities — availability of the top 20 priority cancer medicines ranges from just 9% to 54% in low- and lower-middle-income countries, compared with 68% to 94% in high-income countries
<iframe src="https://hindustansphere.com/embed/cluster/4c630c7eb2882cffefe1ad1c03b5d9c2ce343e85" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Why cancer cases are rising worldwide | Explained"></iframe>
Global Status Report on Cancer 2026: Cancer disparities — availability of the top 20 priority cancer medicines ranges from just 9% to 54% in low- and lower-middle-income countries, compared with 68% to 94% in high-income countries
